Investigation of benzimidazole anthelmintics as oral anticancer agents
Authors:
Open Access
- 8 April 2022
- journal article
- research article
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 43 (5) , 750-756
Abstract
Recently, there has been social controversy regarding whether benzimidazole anthelmintic drugs can be used as anticancer drugs. On this note, we wish to address the use of current benzimidazole anthelmintic drugs for the treatment of cancer patients. We explored the anticancer efficacy of benzimidazole anthelmintic drugs in vitro and their mechanism of action. We also conducted pharmacokinetic studies of two benzimidazole anthelmintics and assessed the predictive systemic efficacy. Finally, we present the anticancer efficacy of benzimidazole anthelmintics' putative metabolites from hydrolysis. Our data suggest that benzimidazole anthelmintic drugs are not expected to show systemic anticancer efficacy in vivo due to poor pharmacokinetic parameters. Therefore, patients should not consider oxibendazole or fenbendazole as cancer treatment option.Keywords
Funding Information
- Korea Research Institute of Chemical Technology (KK2231‐20, SI2231‐40)
This publication has 29 references indexed in Scilit:
- Targeting Glucose MetabolismAmerican Journal of Clinical Oncology, 2011
- Nocodazole is a High‐Affinity Ligand for the Cancer‐Related Kinases ABL, c‐KIT, BRAF, and MEKChemMedChem, 2011
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvateBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma CellsMolecular Cancer Research, 2008
- A possible model of benzimidazole binding to β-tubulin disclosed by invoking an inter-domain movementJournal of Molecular Graphics and Modelling, 2004
- G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cellsJournal of Clinical Investigation, 2002
- Pharmacokinetics of fenbendazole in dogsJournal of Veterinary Pharmacology and Therapeutics, 1990
- The pharmacokinetics of fenbendazole and oxfendazole in cattleVeterinary Research Communications, 1984
- Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulinBiochimica et Biophysica Acta (BBA) - General Subjects, 1978